Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;29(8):5297-5306.
doi: 10.1245/s10434-022-11574-5. Epub 2022 Mar 22.

Construction and Verification of Risk Predicting Models to Evaluate the Possibility of Venous Thromboembolism After Robot-Assisted Radical Prostatectomy

Affiliations

Construction and Verification of Risk Predicting Models to Evaluate the Possibility of Venous Thromboembolism After Robot-Assisted Radical Prostatectomy

Xu Cheng et al. Ann Surg Oncol. 2022 Aug.

Abstract

Background: Venous thromboembolism (VTE) is the second leading cause for death of radical prostatectomy. We aimed to establish new nomogram to predict the VTE risk after robot-assisted radical prostatectomy (RARP).

Methods: Patients receiving RARP in our center from November 2015 to June 2021, were enrolled in study. They were randomly divided into training and testing cohorts by 8:2. Univariate and multivariate logistic regression (model A) and stepwise logistic regression (model B) were used to fit two models. The net reclassification improvement (NRI), integrated discrimination improvement (IDI), and receiver operating characteristic (ROC) curve were used to compare predictive abilities of two new models with widely used Caprini risk assessment (CRA) model. Then, two nomograms were constructed and received internal validation.

Results: Totally, 351 patients were included. The area under ROC of model A and model B were 0.967 (95% confidence interval: 0.945-0.990) and 0.978 (95% confidence interval: 0.960-0.996), which also were assayed in the testing cohorts. Both the prediction and classification abilities of the two new models were superior to CRA model (NRI > 0, IDI > 0, p < 0.05). The C-index of Model A and Model B were 0.968 and 0.978, respectively. For clinical usefulness, the two new models offered a net benefit with threshold probability between 0.08 and 1 in decision curve analysis, suggesting the two new models predict VTE events more accurately.

Conclusions: Both two new models have good prediction accuracy and are superior to CRA model. Model A has an advantage of less variable. This easy-to-use model enables rapid clinical decision-making and early intervention in high-risk groups, which ultimately benefit patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
ROC curves of two new models and Caprini scores in the training cohort (A) and in the testing cohort (B). Model A, univariate and multivariate logistic regression model; Model B, stepwise logistic regression
Fig. 2
Fig. 2
Calibration curve of model A and B. X-axis: risk prediction of VTE in patients. Y-axis: actual diagnosed VTE. The more solid bias corrected line was closed to ideal line, the better prediction capacity. Model A, univariate and multivariate logistic regression model; Model B, stepwise logistic regression
Fig. 3
Fig. 3
The nomogram obtained from model A (A) and model B (B). Model A, univariate and multivariate logistic regression model; Model B, stepwise logistic regression
Fig. 4
Fig. 4
Decision Curve Analysis curve of model A, model B, and CRA model in training cohort (A) and testing cohort (B). Model A, univariate and multivariate logistic regression model; Model B, stepwise logistic regression
Fig. 5
Fig. 5
Clinical impact curve of CRA model (A), model A (B), and model B (C). Model A, univariate and multivariate logistic regression model; Model B, stepwise logistic regression

Similar articles

Cited by

References

    1. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res. 2009;53(2):171–184. doi: 10.1002/mnfr.200700511. - DOI - PubMed
    1. Ilic D, Evans SM, Allan CA, et al. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer. Cochrane Database System Rev. 2017 doi: 10.1002/14651858.cd009625.pub2. - DOI - PMC - PubMed
    1. Kucera R, Pecen L, Topolcan O, et al. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11(3):399–418. doi: 10.1007/s13167-020-00214-1. - DOI - PMC - PubMed
    1. Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898–3944. doi: 10.1182/bloodadvances.2019000975. - DOI - PMC - PubMed
    1. Alberts BD, Woldu SL, Weinberg AC, et al. Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations. Urology. 2014;84(4):799–806. doi: 10.1016/j.urology.2014.05.055. - DOI - PubMed

LinkOut - more resources